Dr. David Samadi is a board certified urologic oncologist trained in open and traditional and laparoscopic surgery and is an expert in robotic prostate surgery. Read the blog to find helpful information.
Have you received the prostate cancer diagnosis? If yes, you may have probably been taken aback, felt distressed or even depressed. These feelings are absolutely normal, taking into account that we all love life and do our best to care for it.
The present article is here to lower your panic and provide accurate and reliable information about what to expect after a prostate cancer diagnosis. Dr. David Samadi, Urologic Oncology Expert at Lenox Hill Hospital, New York, explains what the latest studies reveal about the best conduct after being diagnosed with prostate cancer.
Important facts about prostate cancer
Prostate cancer is that type of disease that has a slow progression rate and may give no significant symptoms. This is the reason why many men are being thunderstruck when receiving a prostate cancer diagnosis.
Also, you need to know that there are different stages of prostate cancer. Some prostate cancers are discovered at their incipient stages, when they may need minimal or even no treatment. Cancers that are discovered at a more advanced stage, are usually more aggressive and can spread quickly.
If you are one of the readers of this article who was not diagnosed with prostate cancer, Dr. Samadi recommends having prostate cancer screening regularly. It is already widely known that early-stage prostate cancer does not cause significant symptoms and screening has the goal of discovering cancer before it is spread. It is recommended to begin your prostate screening with a PSA test.
If you are one of the many men in America diagnosed with prostate cancer, it is a matter of the utmost importance to know the exact stage of your cancer in order to decide what action path to follow.
What to do if you have been diagnosed with localized prostate cancer
If after following all the recommended tests, your doctor tells you that you have localized prostate cancer, this means your cancer has not spread outside the prostate gland. You probably have few or no symptoms. It is worth knowing that there are many treatments for localized prostate cancer. Doctors usually recommend surgery or radiation therapy but the latest studies conducted over a 10-year period revealed that the active surveillance approach proved to be effective for many men diagnosed with prostate cancer.
What does active surveillance mean?
Active surveillance differs from watchful waiting, representing the close monitoring of the prostate gland at regular checkups. During the active surveillance period, the doctor may perform different types of tests in order to establish if there are any abnormal changes concerning prostate cancer. Compared to the watchful waiting approach, the active surveillance results are not based merely on the symptoms’ changes but on the tests that are regularly performed, such as the digital rectal exam, the PSA blood test, biopsy or other available tests used to monitor the cancer growth.
Only if the tests reveal that cancer starts to grow, the doctor will discuss the treatment options suitable for your particular condition.
What do studies show about active surveillance?
The active surveillance approach is being widely accepted as an alternative option for treating prostate cancer. During the last 10 years, many Urologist Experts adopted the active surveillance, considering it an effective alternative to conventional prostate cancer treatments that are, in some cases, unnecessary.
Researchers who published a 10-year study on prostate cancer showed that men who adopted the active surveillance approach did not experience a higher mortality rate than the ones who underwent a surgical treatment or a type of radiation therapy.
You need to remember, the active surveillance is effective only if the cancer is low-grade and newly diagnosed.
These positive results of active surveillance in men with early-stage cancer made this approach a common option on the list of localized prostate cancer treatments.
If you are thinking of adopting this approach, contact your doctor for customized advice.
What are the typical treatment options for prostate cancer?
It is important to know that there are surgical and non-surgical prostate cancer treatments.
Dr. Samadi is performing a superior surgical prostate cancer treatment, which is the robotic prostate surgery, using the da Vinci robotic system.
These surgical treatments proved a success rate of almost 100%.
The non-surgical prostate cancer treatments are:
The prostate cancer hormone therapy
Prostate Cancer Radiation
HIFU (High-Intensity Focused Ultrasound), which is an experimental prostate cancer treatment that is not FDA approved yet.
If you are now balancing all the pros and cons of the many prostate cancer treatments available, do not forget to consider the active surveillance approach. Gather all the facts, get thoroughly informed about the treatment options and decide based on your personal condition.
If you want to benefit from professional advice, book an appointment with Dr. David Samadi!
The UroLift system represents an innovative treatment for men suffering from BPH (Benign Prostatic Hyperplasia). BPH symptoms can be very severe and cause important issues in day-to-day life. The Prostatic Urethral Lift Procedure is here to offer rapid and long-lasting relief from these distressing symptoms.
The enlargement of the prostate blocks the urethra, resulting in a urination blockage. The symptoms associated with BPH affect men’s quality of life, physically and emotionally. Whether we talk about the urgency to urinate, incontinence or sexual dysfunctions, BPH symptoms are hard to cope with.
In their search for relief and desire to resume their normal lives, most men take prescription medications. Contrary to their expectations, these medications can cause extreme tiredness or even sexual dysfunctions. If you do not want to start taking a pill for BPH or if you are unsatisfied with BPH medication effects, the UroLift treatment may be right for you!
Why choose the Prostatic Urethral Lift Procedure?
Treatment with the UroLift system is a minimally-invasive surgical technique that rapidly relieves BPH symptoms so that men can resume their daily activities right away.
Compared with other more invasive surgical procedures available, the UroLift procedure is painless and involves a very short recovery period. It provides a significant improvement in patients’ quality of life not only because it effectively treats the lower urinary tract symptoms caused by BPH, but also because it preserves the sexual functions.
How does the UroLift procedure work?
The UroLift system is a simple procedure that is usually performed in a doctor’s office. The doctor uses tiny stainless-steel implants that lift and hold the enlarged prostate tissue so that it no longer blocks the urethra. This revolutionary treatment does not require heating, cutting or removal of the prostate tissue, as is happens in other major surgeries.
The UroLift system is addressing the root of the problem, the blockage of the flow of urine. After the UroLift device in removed, it leaves an open urethra, unblocking the urine path and providing rapid relief.
This type of procedure is usually performed under local anesthesia in a physician’s office or ambulatory surgery center. Typically, patients can return home the same day without a catheter and resume their normal activities.
What are the main benefits of the UroLift procedure?
The UroLift prostatic urethral lift is more effective at relieving BPH symptoms than any medication, filling the gap between prescription medication and major, invasive surgeries.
It can be performed under local anesthesia in a doctor’s office in about one hour.
For most patients, the fact that this treatment preserves the sexual function represents one of the most important benefits.
It is also a catheter-free post procedure and can discontinue medical therapy afterwards.
What are the most common side effects of the UroLift procedure?
As it happens with any medical procedure, the UroLift system treatment may cause a number of side effects, but these are mild to moderate. Over 95% of the adverse events reported in published studies did not require any form of treatment or surgical intervention. These side effects may include:
pain or burning with urination
the presence of blood in the urine ( hematuria)
pelvic pain or an uncontrolled need to urinate( urgency)
These adverse events should not be worrisome, considering that they usually resolve within two to four weeks after the procedure.
Who can be selected to undergo the UroLift system procedure?
Patient selection is performed carefully, as it provides the key to the procedure’s rate of success. As stated in most studies, there are three overall exclusion key factors.
Firstly, if the BPH symptoms are caused by the obstruction of the median lobes, men should have a cystoscopy prior to the surgery in order to exactly determine the volume of the prostate. In this case, the UroLift procedure may be contraindicated.
Secondly, the UroLift procedure is not recommended for men with large prostate volume (more than 100 ml). If the prostate volume is between 20 and 70 ml the patient can be a candidate for the UroLift procedure.
Finally, patients with a history of urinary retention or with an active urinary tract infection are not suitable to undergo the UroLift system treatment.
What is the success rate of Urolift?
The long term results show sustained benefits of the UroLift system treatment and the five years data available proves the efficiency of this innovative solution. The positive outcomes are rapid and durable, including an IPSS (International Prostate Symptom Score) improvement. The studies have also demonstrated that the urinary flow rate significantly improved. The UroLift procedure is also having a low retreatment rate, of approximately 13,6% in a five years period.
What is more, the UroLift system proved to be the only BPH procedure that preserves the sexual function with 100% rate of success. In a global survey that was conducted over 13,000 men, aged between 40-80, from 29 countries, almost 50% of them considered sex as being very or even extremely important.
How long do the benefits of the UroLift system last?
There are a number of published studies on this topic which show that men who underwent the Urolift procedure continue to benefit from it up to 5 years or even longer. The benefits can be more durable if the UroLift treatment is combined with medication, such as Flomax.
Candidates who do not meet all the selection criteria may need further alternative surgeries in 2-4 years after the UroLift treatment. The patients should be counselled and carefully selected before undergoing this procedure.
It is worth considering that the ideal candidates for the UroLift system treatment experience excellent relief of their BPH symptoms for 5 years or longer.
The UroLift system demonstrated its efficiency as a revolutionary treatment for BPH symptoms. It is the only safe and durable BPH procedure that can improve life’s quality and preserve sexual function.
Set an appointment today to find out if the UroLift system is right for you!
The first step toward understanding how the prostate affects your health is to learn what the prostate is and how it functions. The prostate gland is about the size of a walnut and surrounds the neck of a man’s bladder and urethra – the tube that carries urine from the bladder. It is partly muscular and partly glandular, with ducts opening into the prostatic portion of the urethra. It is made up of three lobes: a center lobe with one lobe on each side.
One of the most important prostate functions is the secretion of alkaline fluid that adds to the bulk of the semen. Semen is a mixture of fluid from three accessory male sex glands i.e. seminal vesicles, bulbourethral and prostate; semen is discharged during ejaculation in men and contains sperms. The prostate gland makes up an important component of the human male reproductive system. So let’s take a deeper look at this gland with some facts you’re likely not familiar with.
9 Facts About The Prostate Gland
It boosts your sexual capability – Prostate gland secretions comprise a large portion of seminal fluid and proper function of the gland is crucial to sexual capability in men.
Your prostate has five areas – The prostate gland contains five areas, or zones. The peripheral zone is the largest segment, containing about 75% of the glands in the prostate. Most prostate cancer occurs in the peripheral zone and is the site where most needle biopsies are taken.
It’s fueled by testosterone – The prostate gland is dependent on testosterone for it to function.
It’s hugging your urethra as we speak – It completely surrounds the urethra, which is the tube that takes urine and sexual fluids through the penis and out of the body.
It’s another muscle that needs work – The prostate gland contains muscles which help in expelling the semen out of the penis during sexual intercourse.
It’s where semen is made – Semen is produced by both the prostate gland and the seminal vesicles, a pair of glands attached to the prostate.
It spares you of some awkward leakage – The prostate gland is also responsible for sealing off the entry from the bladder into the urethra with the help of a muscle called a sphincter. This prevents the flow of urine during sexual intercourse.
It’s the size of a walnut – A normal prostate gland is approximately 1½ inches long and weighs about an ounce.
It keeps out the bad stuff – The prostate also filters and removes toxins for protection of the sperm, which enhances the chance of impregnation and ensures that men seed with the optimum quality of sperm.
An enlarged prostate, also known as benign prostatic hyperplasia (BPH), is a disorder that generally tends to affect men as they age. With age, the cells of the gland begin to multiply, leading to an enlarged prostate. An enlarged prostate is problematic because it presses on the urethra, creating difficulties with urination and weakening the bladder. BPH will produce symptoms such as weak or interrupted urine stream, inability to urinate, difficulty starting or holding urination, and the need to frequently urinate, especially at night.
Ignoring prostate problems, as some men tend to do, isn’t a smart idea. If left untreated, an enlarged prostate can block the flow of urine out of the bladder, leading to other complications such as urinary retention and kidney damage. Below are some natural remedies you can try at home to ease symptoms of BPH.
A sitz bath is an old fashioned method that really works when it comes to soothing an enlarged prostate. The hot bath relaxes the pelvic muscles, and promotes healing. The cold bath eases pain and reduces swelling. For this method you just need to fill the bathtub with the warm water and then add ½ cup of Epsom salt to it. And, in another bathtub (or large container), you fill with cold water and add several drops of lavender essential oil to the bathtub. Now, you sit in the bathtub containing hot water for about 3 minutes. Then, move to the one with cold water for 1 minute.
Stinging nettle leaves may cause sharp, intense pain, but its extract has benefits for the prostate. The root contains essential bioactive phytochemicals that help shrink prostate tissue. Being a natural diuretic, it also encourages the elimination of inflammatory wastes through urination. You can have stinging nettle as a drink by simply adding 1 teaspoon of dried leaves in hot water. Let it sit for 10 minutes, then strain. You can drink this tea mix 2 to 3 times daily. Always consult your physician before taking any supplement to determine the correct dosage for your size and condition.
Pelvic-strengthening or kegel exercises could help in easing some of the discomforts of an enlarged prostate because they are useful in tightening and clenching specific pelvic muscles to help control the urination. You just need to empty your bladder and lie on the ground with the knees bent and apart. Then, gently tighten the pelvic floor muscles for about 5 seconds before relaxing them for 5 seconds. However, men who are suffering from chronic prostatitis or chronic pelvic pain syndrome should avoid doing this type of exercise.
Apple Cider Vinegar
Apple cider vinegar is very good for your prostate. The unfiltered, raw apple cider vinegar features astringent properties, helping shrink the swollen prostate glands. Also, it aids weight loss and helps prevent complications of enlarged prostate such as UTIs. You simply need to mix 1-2 tablespoon of raw, unfiltered apple cider vinegar with 1 tablespoon of honey in one glass of warm water. Drink this at least twice per day. Another option with apple cider vinegar is adding about 1 cup to a bathtub of cool water and soaking in it for about 10 minutes.
The enlargement of the prostate can’t be cured naturally, but there are changes in lifestyle and diet that can be made in order to prevent this painful condition. Practicing an active lifestyle with physical activities, drinking plenty of liquids, having a healthy diet and limiting alcohol consumption are natural ways of preventing prostate enlargement, among other illnesses. What men should include more in their regular diet is astragalus and soy. Astragalus is an old chinese medicinal plant that boosts the immune system in cancer patients, but is also helpful in reducing the effects of BPH. Soy, on the other hand, maintains prostate health and protects agains benign prostatic hyperplasia. A diet of the two combined can be of tremendous help for men against prostate diseases.
Early stage prostate cancer usually has no warning signs. The cancer could only raise concern if the tumor happens to press on the urethra and cause changes to your urine flow. Because the cancer typically appears in a different part of the prostate, there are no symptoms in the early stage of prostate cancer. The only way to detect prostate cancer in the early stages is to get an annual PSA test, especially if you check one or more of the risk factors:
you are a male over the age of 50
there is prostate cancer history in your family (especially if your father or brother have had it)
you are African American (African American men are 1.7 times more likely to be diagnosed with prostate cancer than white men).
The signs of prostate cancer generally become more noticeable in the advanced stages of the disease. Prostate cancer symptoms are not usually caused by the cancer itself, but rather as a result of blockage caused by the increased growth of the prostate gland. This growth can affect a man’s sexual performance and also cause urinary tract difficulties. This is why it’s imperative to have a yearly check-up done in order to catch prostate cancer in the early stages when it can be treated more effectively.
What are the signs of prostate cancer?
If you experience any or more of the symptoms below, it’s a warning sign that you have to go see your GP. In a lot of cases, if the pain is located in your bones or pelvic area, it could be a signal that the cancer has spread.
Below are the 12 signs and symptoms of prostate cancer that should never be ignored in order to prevent the development and progression of the disease.
A Noticeable burning while urinating or during ejaculation
A frequent need to urinate
Difficulty starting or stopping a stream of urine
A weak or dribbling flow of urine
Inability to urinate standing up
Weak or decreased flow in your urinary stream
Feeling a need to hold back while urinating
Blood in urine
Blood in semen
Pain in the bones
Pain and discomfort in the pelvic area, lower back or upper thighs
Symptoms associated with prostate cancer can also be caused by other non-cancerous diseases, such as a urinary tract infection (UTI) or benign prostatic hyperplasia (BPH). The latter is often confused as prostate cancer. Your doctor can help to diagnose your exact condition and address any of the issues listed above with treatment.
When to contact your doctor
Be sure to contact your doctor if you are experiencing any of the above symptoms. Prostate cancer symptoms in the advanced stages can also have similarities to other cancers. Some of these symptoms include:
Chronic pain in your lower back, pelvis, and upper thigh bones. Pain in these areas is caused by the spread of prostate cancer (metastasis).
Fatty Acids Tied To Prostate Cancer Growth, Study Reveals
A new study has revealed that high levels of fatty acids are linked with prostate cancer growth — and blocking these fatty acids may slow that growth in patients.
Forging the Link
One of the most common types of cancer that men are diagnosed with, prostate cancer typically grows rather slowly. However, even in the face of this slow growth, halting the progression of prostate cancer to more aggressive stages can be challenging.
This has prompted research into ways to identify factors in prostate tumor growth, exemplified by a new study recently published in the journal Science Translational Medicine. Scientists discovered that fatty acids are used by prostate tissue to fuel growth. Not only that, but reducing the availability of fatty acids to these tumors reduced their severity by a significant amount.
After identifying the link between fatty acids and tumor growth, researchers further investigated the process that facilitated that growth. CD36, a specific protein known for its ability to act as a translocase for fatty acids, was found to be the specific culprit when it came to fatty acids being taken up by prostate cancer tissues.
The researchers focused their efforts on either inhibiting or ablating CD36 to see if it had an effect on the ability for prostate tumors to use fatty acids for growth. The tests were successful in reducing prostate cancer severity in both human and mouse preclinical models.
The Future of Prostate Cancer Research?
For now, it’s much too early to expect CD36 inhibitor medications or any other types of related treatments to make it into the hands of doctors any time soon as this research is still preliminary. However, with these very promising early preclinical results indicating the strong role CD36 plays in feeding prostate tumor cells the fatty acids they need to grow, it’s highly likely that there is going to be additional research into developing methods for controlling this fatty acid transfer function in the very near future.
Being able to bring a reliable tool to reduce prostate cancer tumor growth rates could spell the difference for many men in the future when it comes to survivability and quality of life. It’s practically guaranteed that further research will build on these early successes in order to find out if suppressing CD36 is a safe and reliable way to fight prostate cancer.
African-American Men Respond Better to Some Prostate Cancer Treatments, New Study Says
A new research study, soon to be presented at a major symposium in San Francisco, California, is set to reveal how African-American men seem to respond better than white men to some prostate cancer treatments.
Addressing the Disparity
For quite some time, scientists have found evidence that prostate cancer seems to strike African-American men at higher rates than white Americans. Research into this racial disparity has been halting at first, but new efforts to address both the disparity between diagnosis rates, and the disparity between research into African-American men, have sought to correct this oversight.
One recent study that attempted to do just that has uncovered some intriguing results. Research results, poised to be revealed at the 2019 Genitourinary Cancers Symposium in San Francisco, has found that a certain subset of African-American prostate cancer sufferers responds more favorably to specific cancer medications than white men diagnosed with the same types of prostate tumors. In fact, even after taking into account other factors, these African-American men lived 20 percent longer than their white counterparts.
Details of the Study
Researchers from the Duke University School of Medicine used data from the Veteran’s Health Administration in the form of five years of records, ranging from 2013 to 2018. 2,183 white men, and an additional 787 African-American men, all of whom had been diagnosed with metastatic forms of prostate cancer, were included in this research data. The goal of the study was to understand the role that specific medications played in the treatment of these highly aggressive forms of prostate cancer in both white and African-American men.
The two medications, newer ones known as abiraterone acetate and enzalutamide, were found to have extended life expectancies of African-American patients by 20 percent more than they did for white patients. Average life expectancies for patients taking these drugs increased from 26 months to 30 months in African-Americans, even after adjusting for clinical and demographic characteristics.
What the Results Mean
Researchers are intrigued by the results, as this raises the possibility of treatment approaches that can be specifically tailored to male populations that are more susceptible to prostate cancer. The possibilities of discovering both why African-American men respond better to these different drugs than white men and why African-American men seem to be diagnosed at higher rates as well could lead to novel and more effective treatments in the future for all men.
18 Months of ADT Found Optimal for Prostate Cancer Treatment
New research has found that androgen deprivation therapy (ADT), when combined with radiotherapy, is most effective for a period of around 18 months when treating prostate cancer.
Pinning Down the Optimal Time Frame
ADT is one of the most common treatments for locally advanced prostate cancer, especially when undertaken in conjunction with external-beam radiotherapy. Yet the exact amount of time for a patient to spend undergoing ADT has for many years been up to interpretation; doctors and scientists knew that it worked, but minimum (and maximum) treatment cycles were highly variant.
But new research into the optimal time frame for ADT, when combined with radiotherapy, has revealed what may be the most effective length of time for patients to undergo treatment. Scientists have discovered that an 18-month cycle of ADT and radiation therapy was much more effective in reducing mortality rates than a much shorter 6-month cycle, with an effective size difference of around 30 percent.
Pinning Down the Duration
This hasn’t been the first research study of its kind that has attempted to pin down optimal ADT duration times. An older study, which sought to determine the best timeframe for patients to tolerate medium to long-term ADT, found that the most tolerable length of time for androgen deprivation therapy was around 18 months when weighed against the possible health benefits of the treatment. In fact, that study found that treatment periods over 18 months had no further benefit and perhaps even made things worse for a patient.
Truth be told, “standard” ADT treatment timelines can range from between 6 months at the shortest to 36 months at the longest, dependent on the aggressiveness of a patient’s prostate cancer. With the side effects of androgen deprivation well-documented and often distressing, it makes sense for doctors and patients alike to strive for a balance point where the benefits of treatment aren’t outweighed by the possible drawbacks. This new study helps pin down that point in a more definitive manner.
Good News For Anyone Facing ADT
All of this research adds up to good news for anyone who’s facing a round of ADT and is worried about what they’re going to experience as a result. Setting maximum treatment time at 18 months ensures you’ll receive the maximum benefit from the treatment while minimizing the impact of any possible side effects. Knowing that you’re not going to be asked to withstand the treatment any longer than that is a major reassurance
Cancer Mortality Rates Down 27% Over 25 Years, Says New Report
Newly released statistics have shown that cancer mortality rates — including mortality rates linked to prostate cancer — have declined by 27 percent over the last 25 years due to advances in prostate cancer treatment.
First the Good News
The good news, shared by the American Cancer Society, is indeed cause for celebration. The Society’s research found that from 1991 through 2016, thanks to advances in prostate cancer treatment such as robotic prostatectomies, more than 2.6 million patients that could have otherwise died from cancer have instead survived. Nestled among those 2.6 million are numerous men that have survived prostate cancer diagnoses. In fact, prostate cancer became less fatal at a rate of around 51 percent from 1993 to 2016, a major accomplishment.
Some medical professionals have raised the question of how the 2011 decision to de-prioritize screening for prostate-specific antigen would affect prostate cancer diagnosis, treatment, and, ultimately, mortality rates. While diagnosis rates have declined slightly since the decision was made, mortality rates for prostate cancer have flattened from 2013 to 2016, indicating that the decision has not led to an appreciable uptick in prostate cancer-related deaths. This is yet another piece of good news, showcasing that our ability to treat prostate conditions has grown.
Not Quite All Sunshine and Roses
Declining cancer rates overall, and prostate cancer specifically, is indeed excellent news. Yet there are some not-so-bright spots as well, particularly when the study looked at cancer types associated with obesity. In fact, every cancer linked with obesity experienced increasing death rates. Additionally, one out of every three instances of liver cancer deaths have obesity as a contributing factor.
There are other causes for concern as well, with many of these coming down along ethnic or socioeconomic lines. Poverty-stricken communities have higher instances of smoking and obesity and are less likely to have access to affordable healthcare, resulting in higher mortality rates. Additionally, in 2016 cancer mortality rates for African-Americans were 14 percent higher overall when compared to white Americans, though this still compares favorably to the 33 percent disparity in 1993.
In this way, even some of the bad news is still pretty good. Closing the ethnic and socioeconomic gap can be resolved through better education and health care access, while new research is ongoing into treating the types of cancer we do know about. That includes prostate cancer. In another 25 years, we may be able to reduce that mortality rate even further!
Is Their A Link Between Androgen Deprivation Therapy And An Overactive Bladder?
Scientists have discovered a link between androgen deprivation therapy and an overactive bladder.
ADT Might Make You Pee
Androgen deprivation therapy, according to a new research study, has a much higher association with men developing overactive bladder. How much higher an association is crystal clear, as scientists found that healthy men have a 98% reduced risk of being diagnosed with overactive bladder when compared to men with a prostate cancer diagnosis being treated by ADT.
In fact, even in men with prostate issues, ADT was found to be particularly highly associated with overactive bladder. The research study also compared overactive bladder rates between prostate cancer patients treated with ADT and patients diagnosed with benign prostatic hyperplasia (BPH), with the latter being treated with alpha blockers; in this case, the BPH patients still had a 30% reduced risk of developing overactive bladder, even in light of urological problems that BPH can sometimes cause.
You Can Have One Without the Other
There’s nothing in the research that says you’re guaranteed to develop an overactive bladder if you do receive a hormone therapy like ADT for prostate cancer. Not only that, but you can suffer from overactive bladder without even being diagnosed with prostate cancer. In other words, you can have one without the other, though it is common to have urological complications when it comes to prostate issues.
That being said, documenting the high crossover rate between ADT and overactive bladder means that doctors can help prepare patients for the possibility that they’ll develop overactive bladder as a result of treating their prostate cancer. Androgen deprivation therapy remains a highly effective treatment method for low to moderate-risk prostate tumors and is likely to continue to be.
Better Than Some Other Outcomes
Let’s be honest — nobody likes the idea of having to deal with an overactive bladder on top of being treated with ADT for a prostate tumor. At the same time, though, overactive bladder problems are better than other outcomes associated with some prostate cancer treatments; even a side-effect like overactive bladder is much preferable than those possible with other treatments, like radiation.